Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Calliditas
Marketing
Asahi Kasei wraps years of global dealmaking into a single brand
Asahi is rolling its pharma units up under a single brand and forging ahead with efforts to drive sales toward $2 billion by the end of the decade.
Nick Paul Taylor
Oct 1, 2026 7:16am
Asahi Kasei moves to buy Calliditas for more than $1B
May 28, 2024 11:19am
FDA grants Calliditas full nod for kidney disease drug Tarpeyo
Dec 20, 2023 5:24pm
Europe blesses Calliditas' kidney disease drug Kinpeygo
Jul 18, 2022 11:09am
In flurry of activity, EMA issues nods for Sanofi, Lilly drugs
May 20, 2022 10:46am
Calliditas launches IgA kidney disease education campaign
May 20, 2022 9:35am
